NVIDIA Corporation (NVDA) is currently trading at $212.06. Based on 58 Wall Street analysts, the average target price is $302.83, implying a 42.8% upside. The consensus recommendation is STRONG BUY.

NVDA

NVIDIA Corporation

ITOpinion: strong buy

Opinion Criteria: Based on the consensus of Wall Street analysts. Strong Buy (1.0-1.5), Buy (1.5-2.5), Hold (2.5-3.5), Sell (3.5-4.5), Strong Sell (4.5-5.0).

Price (USD)

$212.06

Consensus target price range

Low–high band from analyst PT changes in the last 3 months; median & sample mean vs current price

LowHigh
$250.00$500.00
Current $212.06
Median: $300.00Mean: $315.91Current: $212.06

Recent price target updates (latest 80)

  • KeybancJul 14, 2026

    PT action: Raises

    $310.00 → $330.00

  • China RenaissanceJun 5, 2026

    PT action: Announces

    $0.00 → $319.00

  • NeedhamJun 2, 2026

    PT action: Maintains

    $270.00 → $270.00

  • DA DavidsonJun 1, 2026

    PT action: Maintains

    $300.00 → $300.00

  • Tigress FinancialMay 27, 2026

    PT action: Raises

    $360.00 → $425.00

  • UBSMay 21, 2026

    PT action: Raises

    $275.00 → $280.00

  • Evercore ISI GroupMay 21, 2026

    PT action: Raises

    $352.00 → $413.00

  • DA DavidsonMay 21, 2026

    PT action: Maintains

    $300.00 → $300.00

  • Truist SecuritiesMay 21, 2026

    PT action: Raises

    $287.00 → $307.00

  • RBC CapitalMay 21, 2026

    PT action: Raises

    $250.00 → $270.00

  • Cantor FitzgeraldMay 21, 2026

    PT action: Maintains

    $350.00 → $350.00

  • WedbushMay 21, 2026

    PT action: Raises

    $300.00 → $330.00

  • StifelMay 21, 2026

    PT action: Raises

    $250.00 → $282.00

  • JP MorganMay 21, 2026

    PT action: Raises

    $265.00 → $280.00

  • JefferiesMay 21, 2026

    PT action: Raises

    $275.00 → $300.00

  • Morgan StanleyMay 21, 2026

    PT action: Raises

    $285.00 → $288.00

  • RosenblattMay 21, 2026

    PT action: Maintains

    $325.00 → $325.00

  • KeybancMay 21, 2026

    PT action: Raises

    $300.00 → $310.00

  • BenchmarkMay 21, 2026

    PT action: Raises

    $250.00 → $335.00

  • B of A SecuritiesMay 21, 2026

    PT action: Raises

    $320.00 → $350.00

Band uses only the revised target (Current column) from firm actions dated within the last 3 months—not the Prior price.

Avg Target

$302.83

Based on 58 analysts

Analyst Recommendations

Buy (58)Hold (2)Sell (1)

Upside

+42.80%

Market Cap

$5136.31B

Financial & Investment Metrics

Next Earnings Date
Aug 26, 2026D-35
P/E Ratio (TTM)32.47
Forward P/E16.48
P/B Ratio26.28
Dividend Yield0.48%
Return on Equity (ROE)114.29%
Operating Margin65.60%
Debt to Equity6.55
Beta (Volatility)2.21
52 Week Range$164.07 - $236.54
LowCurrent: $212.06High

Latest News

Daily editorial mentioning NVDA

Price target moves

AAPL Leads Upward Revisions as Eight Firms Lift Targets

Upward revisions dominate the latest activity in our dataset, with eight firms raising price targets over the past week compared to three downward adjustments. Data as of June 10, 2026, highlights a concentrated effort among analysts to adjust expectations, particularly within the Information Technology sector.

Firm-level moves

Ticker Firm Dir Prior→Current
AAPL Morgan Stanley Up 330→360
LLY Jefferies Up 1330→1350
CTVA UBS Down 90→86
SHW BMO Capital Down 420→355

Apple saw three distinct target increases from TD Cowen, Maxim Group, and Morgan Stanley, all aligning at a 7.5% implied upside. Meanwhile, NVDA received a notable initiation from China Renaissance at 319. Conversely, the Materials sector faced headwinds, with BMO Capital’s 65-point reduction for SHW standing out as the most significant downward revision of the period. You can track these recent adjustments in full.

Context

While most revisions align with positive momentum, UNH presents an outlier; despite two firms raising their targets to 460 and 466 respectively, the consensus mean remains slightly above the current trading price, resulting in a negative implied upside of -1.4%. This discrepancy suggests that even with analyst optimism, market pricing for the healthcare giant remains ahead of institutional targets.

Read article

Insider Sentiment Index (Last 6 Months)

Counts and listings exclude stock awards, gifts, and option exercises—open-market purchases and sales only.

Buy vs Sell (Count)

Insider Buys: 0Insider Sells: 10

Whale Trades (C-Level Large Buys)

No major insider buying detected recently.

Recent Insider Transactions

DateNamePositionTransactionShares
6/18/2026STEVENS MARK ADirectorSale at price 209.70 - 210.44 per share.885,000
6/4/2026STEVENS MARK ADirectorSale at price 217.66 - 222.38 per share.1,000,000
6/3/2026NEAL STEPHEN C.DirectorSale at price 215.73 per share.15,500
5/27/2026DABIRI JOHN ODirectorSale at price 214.00 per share.625
3/20/2026STEVENS MARK ADirectorSale at price 172.61 - 174.57 per share.221,682
3/20/2026ROBERTSON DONALD F JROfficerSale at price 172.58 - 177.31 per share.5,396
3/20/2026KRESS COLETTE M.Chief Financial OfficerSale at price 171.97 - 177.51 per share.62,650
3/19/2026SHAH AARTI SDirectorSale at price 176.27 - 177.73 per share.19,000
3/18/2026PURI AJAY KOfficerSale at price 181.31 - 182.94 per share.300,000
3/13/2026DABIRI JOHN ODirectorSale at price 184.90 per share.3,004

Frequently Asked Questions

Q. What is the current target price and upside for NVDA?

A. The current target price for NVIDIA Corporation is $302.83, which implies a 42.8% upside from the current price of $212.06. This is based on the consensus of 58 Wall Street analysts.

Q. What is the current analyst recommendation for NVDA?

A. Currently, there are 10 Strong Buy, 48 Buy, 2 Hold, 1 Sell, and 0 Strong Sell ratings. The overall consensus is STRONG BUY.

Q. Are insiders buying NVDA stock recently?

A. Over the past 6 months, there have been 0 insider buys and 10 insider sells. Insider selling is more prominent recently.

Other Promising Stocks in IT

Data provided by Yahoo Finance. This information is for informational purposes only and does not constitute investment advice. We bear no legal responsibility for any investment decisions made based on this data.

Read full disclaimer